Results 31 to 40 of about 41,122 (231)

Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children

The Turkish Journal of Pediatrics, 2016
This study aims to evaluate Helicobacter pylori with clarithromycin resistant genotypes in Manisa region, Turkey. Two hundred patients, who received diagnosis of Helicobacter pylori infection histopathologically, were included.
Yeliz Çağan-Appak, Hörü Gazi, Semin Ayhan, Beyhan Cengiz-Özyurt, Semra Kurutepe, Erhun Kasırga   +5 more
doaj   +1 more source

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?

Antibiotics, 2020
Resistance to clarithromycin and other antibiotics included in the eradication regimen, such as amoxicillin and metronidazole, is important for Helicobacter pylori (H. pylori) eradication.
Young Min Kim, Kyoung Hwa Lee, Jie-Hyun Kim, Soon Young Park, Young Goo Song, Se Yeon Jeon, Hyojin Park   +6 more
doaj   +1 more source

Therapeutic efficacy of macrolides in management of patients with mild COVID-19

Scientific Reports, 2021
Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We testify whether adding azithromycin or clarithromycin to a standard of care regimen was superior to standard of supportive
Alaa Rashad, Asmaa Nafady, Mohammed H. Hassan, Haggagy Mansour, Usama Taya, Shamardan Ezzeldin S. Bazeed, Zaki F. Aref, Mennatallah Ali Abdelrhman Sayed, Hanaa Nafady-Hego, Aida A. Abdelmaksoud   +9 more
doaj   +1 more source

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

Experimental Hematology & Oncology, 2018
Background The objective of this randomized placebo-controlled study was to investigate the efficacy and safety of clarithromycin in combination with bortezomib–cyclophosphamide–dexamethasone (VCD) in patients with newly diagnosed multiple myeloma ...
Henrik Gregersen, Trung Do, Ida Bruun Kristensen, Ulf Christian Frølund, Niels Frost Andersen, Lene Kongsgaard Nielsen, Christen Lykkegaard Andersen, Tobias Wirenfeldt Klausen, Annette Juul Vangsted, Niels Abildgaard   +9 more
doaj   +1 more source

Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts

Respiratory Research, 2017
Background Periostin is a biomarker indicating the presence of type 2 inflammation and submucosal fibrosis; serum periostin levels have been associated with asthma severity.
Kosaku Komiya, Shoichiro Ohta, Kazuhiko Arima, Masahiro Ogawa, Shoichi Suzuki, Yasutaka Mitamura, Satoshi Nunomura, Yasuhiro Nanri, Tomohito Yoshihara, Atsushi Kawaguchi, Jun-ichi Kadota, Bruce K. Rubin, Kenji Izuhara   +12 more
doaj   +1 more source

Poly(lactic acid)/clarithromycin with metals dioxides nanoparticles: Preparation and performance under ultraviolet irradiation

Materials Science for Energy Technologies
Different polylactic acid (PLA) thin films containing clarithromycin and a number of metal oxide nanoparticles (magnesium, titanium, zinc, and nickel) dioxides were created. Low dosages of metal oxides (0.01% by weight) and clarithromycin (0.5% by weight)
Hadeel Adil, Hamsa Thamer, Raghda Alsayed, Muna Bufaroosha, Dina S. Ahmed, Mohammed H. Al-Mashhadani, Hassan Hashim, Amani A. Husain, Emad Yousif   +8 more
doaj   +1 more source

Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin

Case Reports in Oncology, 2023
We encountered a case in which the general condition of a patient receiving cabazitaxel worsened with concomitant use of clarithromycin. Cabazitaxel is metabolized mainly by CYP3A4, and the frequency of adverse events is known to increase with increasing
Shigeaki Katsumi, Takuya Araki, Hideaki Yashima, Yoshiyuki Miyazawa, Kazuhiro Suzuki, Koujirou Yamamoto   +5 more
doaj   +1 more source

Antimicrobial Resistance-Stratified Efficacy of Vonoprazan, Clarithromycin, and Metronidazole Therapy for <i>Helicobacter pylori</i> Eradication in Penicillin-Allergic Patients: A Single-Arm Prospective Interventional Study. [PDF]

JGH Open
ABSTRACT Background Choosing an effective Helicobacter pylori eradication regimen for patients with penicillin allergy remains a clinical challenge. Although vonoprazan‐based regimens yield excellent outcomes in standard populations, we still lack sufficient evidence regarding penicillin‐allergic patients.
Sue S, Ikeda R, Ikeda A, Sato H, Goda Y, Kaneko H, Irie K, Maeda S.   +7 more
europepmc   +2 more sources

Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population [PDF]

Background: In Iran, there is insufficient information on the efficacy of Helicobacter pylori eradication regimens shorter than 10 days. This study aims at assessing the efficacy of 4- and 7-day H. pylori eradication regimens in a high-incidence area of
میکاییلی, جواد, ستوده منش, رسول, پورشمس, اکرم, ملک زاده, رضا, بابایی, مسعود, فره وش, محمد جعفر, عابدی اردکانی, بهنوش, درخشان, محمدحسین, سیاوشی, فریده, دولتشاهی, شهاب, مجیدپور, علی, مرآت, شاهین, عرشی, شهنام, ستوده, مسعود, ناصری مقدم, سیاوش, یزدانبد, عباس   +15 more
core   +1 more source

The challenge of resistance to antibiotics: the comeback of bismuth-based quadruple therapy

Therapeutic Advances in Gastroenterology, 2012
A proton-pump inhibitor (PPI), clarithromycin-based, triple therapy has been the recommended treatment for Helicobacter pylori eradication for the past 15 years. Due to a steady increase in H.
Francis Mégraud
doaj   +1 more source